NASDAQ:EYEN
Eyenovia Inc. Stock News
$0.81
+0.0960 (+13.48%)
At Close: May 31, 2024
Eyenovia, Inc. Prices Public Offering of Common Stock
01:10pm, Wednesday, 19'th Aug 2020
NEW YORK, Aug. 19, 2020 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose array print (MAP™) therapeutics, t
The Daily Biotech Pulse: Gilead's Filgotinib Stumbles With FDA, J&J Laps Up Momenta In $6.5B Deal, 2 IPOs
12:00am, Wednesday, 19'th Aug 2020
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 18)
Avenue Therapeutics Inc (NASDAQ: ATXI)
Checkmate Pharmaceuticals Inc (NASDAQ: CMPI)
DarioHealth Corp (NASDAQ:...
Eyenovia, Inc. Announces Proposed Public Offering of Common Stock
08:03pm, Tuesday, 18'th Aug 2020
NEW YORK, Aug. 18, 2020 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose array print (MAP™) therapeutics, t
Eyenovia, Inc. (EYEN) CEO Sean Ianchulev on Q2 2020 Results - Earnings Call Transcript
11:05pm, Wednesday, 12'th Aug 2020
Eyenovia, Inc. (NASDAQ:EYEN) Q2 2020 Earnings Conference Call August 12, 2020 04:30 PM ET Company Participants Alexander Lobo - The Ruth Group Sean Ianchulev - Chief Executive Officer & Chief Medi
Eyenovia Reports Second Quarter 2020 Financial Results
08:05pm, Wednesday, 12'th Aug 2020
NEW YORK, Aug. 12, 2020 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose array print (MAP™) therapeutics, t
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 11) * Allovir Inc (NASDAQ: ALVR) * Erytech Pharma SA (NASDAQ: ERYP) * Eyenovia Inc (NASDAQ: EYEN) (announced an exclusive collaboration
Eyenovia Eligible to Receive up to a Total of $45.75 million in Upfront Payments and Development and Commercialization Milestones and Development Costs Arctic Vision to Lead Expansion of Novel Approa
The Week Ahead In Biotech: Bausch Health, Fennec Pharma FDA Decisions And Smid-cap Earnings
12:00am, Sunday, 09'th Aug 2020
Biotech stocks advanced in the week ended Aug. 7, buoyed by multiple catalysts. Aside from the broader market strength, mostly positive earnings and continuing coronavirus...
Eyenovia Announces Conference Call and Webcast for Second Quarter 2020 Financial Results
12:30pm, Wednesday, 29'th Jul 2020
NEW YORK, July 29, 2020 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose array print (MAP™) therapeutics, t
3 “Strong Buy” Healthcare Stocks Under $5 That Could Double (Or More)
07:30pm, Monday, 20'th Jul 2020
The healthcare sector took its place among the winners this year, rising 21%, compared to the S&P 500’s 0.5% growth. The bottom-line for investors? Wall Street’s focus is on the healthcare space,
Ocular Therapeutix Is A Good Value Based On Its Strong Technology Platform (NASDAQ:OCUL)
06:02am, Thursday, 09'th Jul 2020
Ocular Therapeutix already has one marketed product and several promising pipeline therapies using its novel implant technology for the treatment of eye diseases.
Eyenovia Resumes Recruitment of Phase III CHAPERONE Study for Progressive Myopia
08:05pm, Tuesday, 30'th Jun 2020
Eyenovia, Inc. (EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose array print (MAP™) therapeutics, today announced that the Company has resumed patient
Eyenovia, Inc. Announces Adjournment of 2020 Annual Meeting of Stockholders to June 30, 2020 and Change to a Virtual Meeting Format
08:10pm, Thursday, 11'th Jun 2020
Eyenovia, Inc. (EYEN) a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing its patented piezo-print delivery technology, today announced that
Eyenovia, Inc. (EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing its patented piezo-print delivery technology, today announced tha
